Ibgħat lil ħabib
RSS
google +
Verżjoni għall-istampar

Aħbarijiet (Drogi illeċiti)

This section on health in the EU has been created as a trustworthy gateway to a wide range of information and data on health-related issues and activities at both European, national and international level. The content is produced by the European Commission, the Member States of the EU and the European Economic Area (EEA), plus EU candidate countries; by international organisations; and by pan-European non-governmental organisations in the area of public health.

Just published: EMCDDA-Europol 2013    europa.eu

This report presents the key activities performed by the EMCDDA and Europol in 2013, with details on all the relevant activities in support of the implementation of Council Decision 2005/387/JHA on t[...]

EMCDDA releases state-of-the-art review on drugs and driving    europa.eu

The EMCDDA releases a state-of-the-art review on drugs and driving today ahead of International day against drug abuse and illicit trafficking.[...]

EU drugs agency places six topics in the spotlight with new online analyses    europa.eu

The EU drugs agency (EMCDDA) releases today alongside its European Drug Report 2014: Trends and developments, six new additions to its Perspectives on drugs (PODs) series. This latest selection of on[...]

Largest multi-city study on drug wastewater analysis released today    europa.eu

The findings of the largest European project to date in the emerging science of wastewater analysis (WWA) are released today in an article published in Addiction. The project in question - steered by[...]

Just published: European Drug Report 2014: Trends and developments    europa.eu

How many new drugs were detected in Europe over the last year? Is cannabis getting stronger? How many Europeans have ever used an illicit drug? What are the latest drug policy developments in the reg[...]

Just published: Risk assessment of methoxetamine    europa.eu

This report presents the data and findings of the risk assessment on the new psychoactive substance, 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone, that was conducted by the Scientific Committee of[...]

Just published: Risk assessment of 25I-NBOMe    europa.eu

This report presents the data and findings of the risk assessment on the new psychoactive substance, 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine, that was conducted by the Scientific[...]

Just published: Risk assessment of MDPV    europa.eu

This report presents the data and findings of the risk assessment on the new psychoactive substance, 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one, that was conducted by the Scientific Com[...]

Just published: Risk assessment of AH-7921    europa.eu

This report presents the data and findings of the risk assessment on the new psychoactive substance, 3,4-dichloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide, that was conducted by the Scientifi[...]

EFSA proposes reduction of maximum levels of zinc in feed    europa.eu

Published on: 5 May 2014 EFSA has proposed a reduction of the maximum permitted content of zinc in feed for all animal species. It is estimated that the new proposed levels will reduce the amount of [...]

Just published: Emergency health consequences of cocaine use in Europe    europa.eu

This study reveals the substantial levels of morbidity related to cocaine use, translated into the large number of cocaine cases seen in various emergency settings in European countries. This health [...]

Just published: Literature review on levels of harm    europa.eu

This report presents the findings of a literature review to identify the most frequently occurring patterns of use and their relation to harm in users of opioids, powder and crack cocaine, and meth/a[...]

Just published: Literature review on levels of harm    europa.eu

This report presents the findings of a literature review to identify the most frequently occurring patterns of use and their relation to harm in users of opioids, powder and crack cocaine, and meth/a[...]

Periodic Report Summary - DOPAMINE NEURON CODE (Developmental Transcription Factors in Dopamine Neuron Maintenance)    europa.eumsw8

KAROLINSKA INSTITUTET Summary description of the project objectives This project aimed at characterising the function of transcription factors expressed in late maturation and adult midbrain dopamine[...]

Final Report Summary - DOPAMINE NEURON CODE (Developmental Transcription Factors in Dopamine Neuron Maintenance)    europa.eumsw8

KAROLINSKA INSTITUTET A fundamental problem in biology has been to understand how the tremendous cellular diversity within the central nervous system is generated during embryonic development. One ce[...]

Disclaimer

The European Commission is solely responsible for information present on EU-level websites, information present in the Portal originated by the Commission. National-level information is provided by the Member States concerned and Member States are solely responsible for the accuracy of the information. Likewise, the European Commission is not responsible for information on non-governmental organisations and international organisations websites. The European Union is committed to user privacy. Read more concerning the Legal Notice.
Further questions can be answered through the Contact page. The Health-EU portal supports principles and measures to increase the credibility of information on the net. It complies with the HONcode standard for trustworthy health information: verify here.